The Company's full financial statements and related MD&A for the first quarter ended September 30, 2024, are available at www.inmedpharma.com, www.sedar.com and at www.sec.gov.

Good afternoon, and welcome, everyone to the Beyond Air Financial Results Call for the Fiscal Quarter Ending September 30, ...

The Biden OMB’s new report on federal regulations leaves many costs unquantified, while Trump’s new term promises a ...

Romania's headline inflation edged up slightly to 4.67% y/y in October from 4.62% y/y in September, as the prices increased ...

For the first quarter of the 2025 fiscal year, the management team at ... it has fallen to 3.4. By the end of this calendar year, the company is hoping to bring its net leverage ratio down to ...

Atmos Energy has provided EPS guidance for Fiscal 2025, projecting an increase to ... APT made its first SSI filing earlier this calendar year, seeking recovery of approximately $19 million ...

Atmos Energy has provided EPS guidance for Fiscal 2025, projecting an increase to between $7.05 and ... APT made its first SSI filing earlier this calendar year, seeking recovery of approximately $19 ...

BEAD is anticipated to significantly boost Dycom's revenue and margin growth from FY 2026, with a peak organic growth ...

The Reserve Bank of India (RBI) has expanded the Fully Accessible Route (FAR) to include 10-year Sovereign Green Bonds for ...

Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, ...

The FTSE 100 index rose 52.80 points, 0.7%, at 8,125.19. The FTSE 250 closed up 203.57 points, 1.0%, at 20,721.49. The AIM All-Share gained 3.57 points, 0.5%, at 737.93.